Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Talmapimod

A selective inhibitor of the p38 alpha kinase (MAPK), a key hub of inflammatory signalling: studied by mouth in rheumatoid arthritis and in the laboratory against multiple myeloma, it showed no benefit over placebo (results published in 2011) and did not reach the market. This family brings together the active ingredient.

Did you know?It is highly selective: it blocks p38 alpha about 10 times more than p38 beta and about 2,000 times more than a panel of 20 other kinases.

TalmapimodGo to the active ingredient →
TalmapimodActive ingredientTalmapimodCat. No. P-T010-001CAS 309913-83-5

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.